FBInvestor
Stocks / Global Blood Therapeutics In
Institutional Ownership

Global Blood Therapeutics In

CUSIP 37890U108COMGBTUSDQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon